A compound of Formula ( I ) wherein L is a bond, -CH 2 -, -CH 2 CH 2 -, -CH 2 CH 2 CH 2 -, -CH 2 CH 2 NH-, -CH 2 C(=O)NH-, -CH 2 C(OH)(H)CH 2 -, or -CH 2 C(OH)(H)CH 2 NH-; R 1 is halo, C 1-5 alkyl, C 3-6 cycloalkyl, or cyclohexylmethyl; R 2 is H, C 1-4 alkyl, hydroxyl, amino, cyano, -CH 2 C(=O)O-( tert -butyl), -CH 2 C(=O)O-(ethyl), -CH 2 C(=O)OH, -NHS(=O) 2 CH 3 , tert -butyl(dimethyl)silyl-oxy, -NHCH 3 , -N(CH 3 ) 2 , -NH-(Isopropyl), optionally substituted phenyl, optionally substituted 5-membered or 6-membered heteroaryl, C 3-6 cycloalkyl, or optionally substituted heterocyclyl; wherein the 5-membered or 6-membered heteroaryl, the heterocyclyl, or the phenyl is optionally and independently substituted with 1-4 substituents selected from the group consisting of: C 1-4 alkyl, -CH 2 -methoxy, -C(=O)OH, -CH 2 C(=O)OH, -C(=O)-O-CH 2 CH 3 , -C(=O)-O-CH 3 , -C(=O)-O-( tert -butyl), -NH 2 , -NHCH 3 , -N(CH 3 ) 2 , -NH-(isobutyl), -NH(CH 2 ) 2 NHC(=O)-O- tert -butyl, -NH(CH 2 ) 2 NH 2 , -NH(CH 2 ) 2 N(CH 3 ) 2 , -C(=O)NH 2 ,-C(=O)CH 3 , oxo, halo, hydroxyl, methoxy, trifluoromethyl, trifluoromethoxy, methoxymethyl, -S(=O) 2 CH 3 , -S(=O) 2 NH 2 , -S(=O) 2 NH(CH 3 ), -S(=O) 2 N(CH 3 ) 2 , -S-CH 3 , cyano, 1H-tetrazol-5-yl, thiophen-2-yl, cyclopropyl, azetidin-1-yl, phenyl, 4'-(trifluoromethyl) phenyl, benzyl, 1,5-dioxa-9-azaspiro[5.5]undecan-9-yl, 5-pyrimidine-2-amine, and pentafluoro-lambda∼6∼-sulfanyl; ring A is selected from the group consisting of: R 3 is H, cyano, methyl, methoxy, halo, or -NH 2 ; R 4 is H, or methyl; and R 5 is H, cyano, halo, CF 3 , or -NH 2 ; or a pharmaceutically acceptable salt thereof. L is a bond, -CH 2 -, -CH 2 CH 2 -, -CH 2 CH 2 CH 2 -, -CH 2 CH 2 NH-, -CH 2 C(=O)NH-, -CH 2 C(OH)(H)CH 2 -, or -CH 2 C(OH)(H)CH 2 NH-; R 1 is halo, C 1-5 alkyl, C 3-6 cycloalkyl, or cyclohexylmethyl; R 2 is H, C 1-4 alkyl, hydroxyl, amino, cyano, -CH 2 C(=O)O-( tert -butyl), -CH 2 C(=O)O-(ethyl), -CH 2 C(=O)OH, -NHS(=O) 2 CH 3 , tert -butyl(dimethyl)silyl-oxy, -NHCH 3 , -N(CH 3 ) 2 , -NH-(Isopropyl), optionally substituted phenyl, optionally substituted 5-membered or 6-membered heteroaryl, C 3-6 cycloalkyl, or optionally substituted heterocyclyl; wherein the 5-membered or 6-membered heteroaryl, the heterocyclyl, or the phenyl is optionally and independently substituted with 1-4 substituents selected from the group consisting of: C 1-4 alkyl, -CH 2 -methoxy, -C(=O)OH, -CH 2 C(=O)OH, -C(=O)-O-CH 2 CH 3 , -C(=O)-O-CH 3 , -C(=O)-O-( tert -butyl), -NH 2 , -NHCH 3 , -N(CH 3 ) 2 , -NH-(isobutyl), -NH(CH 2 ) 2 NHC(=O)-O- tert -butyl, -NH(CH 2 ) 2 NH 2 , -NH(CH 2 ) 2 N(CH 3 ) 2 , -C(=O)NH 2 ,-C(=O)CH 3 , oxo, halo, hydroxyl, methoxy, trifluoromethyl, trifluoromethoxy, methoxymethyl, -S(=O) 2 CH 3 , -S(=O) 2 NH 2 , -S(=O) 2 NH(CH 3 ), -S(=O) 2 N(CH 3 ) 2 , -S-CH 3 , cyano, 1H-tetrazol-5-yl, thiophen-2-yl, cyclopropyl, azetidin-1-yl, phenyl, 4'-(trifluoromethyl) phenyl, benzyl, 1,5-dioxa-9-azaspiro[5.5]undecan-9-yl, 5-pyrimidine-2-amine, and pentafluoro-lambda∼6∼-sulfanyl; ring A is selected from the group consisting of: R 3 is H, cyano, methyl, methoxy, halo, or -NH 2 ; R 4 is H, or methyl; and R 5 is H, cyano, halo, CF 3 , or -NH 2 ; R 3 is H, cyano, methyl, methoxy, halo, or -NH 2 ; R 4 is H, or methyl; and R 5 is H, cyano, halo, CF 3 , or -NH 2 ; <EOS>